Emily Taylor said her 7-year-old son Jerett, who goes by Rett, was first diagnosed with T-cell acute lymphoblastic leukemia ...

But two years later, in July 2025, he felt unwell again and was shocked to discover the leukaemia was back - so he rang his ...

The research on bone-marrow transplantation mirrors the arc of many medical advancements. I was one of the early ...

Kasen Diggs uses his love of golf to battle leukemia. His family is being honored at the American Cancer Society Richmond ...

Sandipan Dhar died in the emergency department at Ramsay Health Care’s Joondalup Health Campus on March 24, 2024 due to ...

By using CRISPR/Cas9 to engineer cells from healthy donors, AVC-203 is designed to circumvent graft-versus-host disease and host-mediated rejection.

Precision Biologics, Inc. announces a new target in Acute Myeloid Leukemia (AML) for CAR-NK therapy. Recent data for several human AML subtypes expressing truncated core 1 O-glycans will be presented ...

Allegations that a former Amityville nurse falsified immunization records of hundreds of children highlight increased ...

Delta-Fly Pharma Inc. is pressing ahead with discussions with the FDA for its lead acute myeloid leukemia (AML) candidate, radgocitabine (DFP-10917), despite a phase III miss on its primary endpoint, ...

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...

PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM AB SCIENCE SECURES EUR 25 MILLION CLINICAL TRIAL INSURANCE FOR ITS PHASE III ...

Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in disease, today announced that multiple abstracts will ...